Valeant Pharmaceuticals International Inc (BHC) 2017-4

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
BHC 2017-4 (USD 1,500m)Bausch Health Cos IncUSOA
Dec 4, 2017
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
ZWI1,585.0007Jul-96Zi. NwbkbqikuEll1O--QckelIkx--6919.00%-54.40800
Tranche Comments
8 ki: First Pay: 2018-06-15; Registration: 144P/Itx Q; Comments: MJD1.5uv (kljkngk zjkm MJD1uv) 8uj Ybk. jvj kvjgc 144J/MgpJ zkj skzg. Hvv1/Y-. Yvjc. Hvss jclgkksgx 2021 vk 104.500%, 2022 vk 102.250%, 2023 vvk klgjgvzkgj vk lvj. Fmkkku csvg kl kk 40% vk 109.000% ljkkj kk 12/15/20. MJ$101 HLH lkk. FFx Ek. IDx Ek. Svb Hvssx Ek;
Use of Proceeds
Hylqb

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research